Completely underreported by our highly rated media are the successful efforts under Operation Warp Speed to develop therapeutics in parallel to vaccines. Eighteen months into this, the reason the mortality rate continues to be driven so low are the new therapeutics that have been under investigation.
Completely underreported by our highly rated media are the successful efforts under Operation Warp Speed to develop therapeutics in parallel to vaccines. Eighteen months into this, the reason the mortality rate continues to be driven so low are the new therapeutics that have been under investigation.
https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-therapeutics-tracker
Here’s a link to the journal article Medical Express is reporting on.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997640/
One of the two-drug combo (NFV) is already in Phase I evaluation in Japan. https://rctportal.niph.go.jp/en/detail?trial_id=jRCT2071200023